Kansas City Clinical Oncology Program

描述(由申请人提供)：堪萨斯城临床肿瘤学计划(KCCOP)预计将过渡到NCORP-KC。它是一个非常成功的非营利性组织，在癌症治疗、癌症症状预防方面进行临床试验。自1983年以来，在国家癌症研究所的不间断资助下，生活质量和癌症控制。该计划位于堪萨斯城大都市区，服务于堪萨斯州和密苏里州16个县和250万居民的需求。该计划由7个组成部分的地区医院和52名调查人员组成，他们代表的专业远远超出内科、外科、妇科和放射肿瘤学的范畴。其他专业领域包括结果研究、内科医学、保健管理、保健信息学、行为科学、康复和生存、姑息治疗、神经学、胃肠病学、遗传咨询、病理学、细胞疗法、实验室科学和放射学。该计划自启动以来，已为4200多名患者和志愿者提供了参与癌症相关试验的机会。在过去的五年里，平均每年有235名新的个人参加。患者满意度和外部审计报告证实，该计划保持了出色的研究质量。该计划的癌症试验来自SWOG、NRG、ANIZATE、CTSU、MD Anderson、URCC和国家癌症研究所的阳光海岸研究基地。NCORP-KC希望感谢其参与者，并通过进入癌症护理提供研究的新时代来扩展其服务，同时继续在癌症治疗、癌症控制、筛查、成像和治疗后监测方面进行高质量的试验。该计划监测趋势，并采取措施继续改进。它在保护患者、他们的安全和健康与提供尽可能广泛的试验激活和少数族裔外展参与之间取得平衡 在反应迅速、负责任的支持人员的帮助下。

DESCRIPTION (provided by applicant): The Kansas City Clinical Oncology Program (KCCOP) expects to transition to NCORP-KC. It is a very successful non-profit organization conducting clinical trials in cancer therapy, cancer symptom prevention. Quality of Life, and cancer control since 1983 with uninterrupted funding by the National Cancer Institute. The program is located in the Kansas City metropolitan area and serves the needs of both Kansas and Missouri residents spread over 16 counties and 2.5 million citizens. The program is comprised of seven component area hospitals and 52 investigators representing specialties well beyond medical, surgical, gynecologic, and radiation oncology. The other areas of expertise include outcomes research, internal medicine, healthcare administration, healthcare informatics, behavioral science, rehabilitation and survivorship, palliative care, neurology, gastroenterology, genetic counseling, pathology, cellular therapy, laboratory science, and radiology. The program has provided participation opportunities to over 4,200 patients and volunteers in cancer-related trials since its inception. Over the last five years, an average of 235 new individuals have participated per year. The program has maintained excellent quality of research as confirmed by patient satisfaction and reports from external audits. The program derives its cancer trials from SWOG, NRG, ALLIANCE, CTSU, MD Anderson, URCC, and SunCoast research bases of the National Cancer Institute. NCORP-KC wishes to thank its participants and extend its service by entering a new era of Cancer Care Delivery Research while continuing to conduct high quality trials in cancer therapy, cancer control, screening, imaging, and post-therapy surveillance. The program monitors trends and implements measures for continued improvement. It balances protecting patients, their safety, and health with providing the broadest possible access to trial activation and minority outreach participation with the help of a highly responsive and responsible support staff.